|
Volumn 20, Issue 9, 2006, Pages 39-40
|
"Eligibility" is key word in Fistula First Breakthrough Initiative in determining fistula use.
a
a
USA
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTERIOVENOUS SHUNT;
BLOOD VESSEL PROSTHESIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
INSTRUMENTATION;
KIDNEY TRANSPLANTATION;
NOTE;
ORGANIZATION AND MANAGEMENT;
OUTCOME ASSESSMENT;
PATIENT SELECTION;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL;
RENAL REPLACEMENT THERAPY;
RISK FACTOR;
STANDARD;
ARTERIOVENOUS SHUNT, SURGICAL;
BLOOD VESSEL PROSTHESIS;
ELIGIBILITY DETERMINATION;
HUMANS;
KIDNEY TRANSPLANTATION;
OUTCOME ASSESSMENT (HEALTH CARE);
PATIENT SELECTION;
PRACTICE GUIDELINES;
RANDOMIZED CONTROLLED TRIALS;
RENAL DIALYSIS;
RISK FACTORS;
|
EID: 33750107655
PISSN: 08961263
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (7)
|
References (0)
|